BioNexus Gene Lab Corp. Introduces BGLC 1Lab Workflow Product
BioNexus Gene Lab Corp. has launched BGLC 1Lab, a new laboratory workflow product, with an initial pilot program at its MRNA Scientific Sdn. Bhd. subsidiary.
Stocks · News reference
BioNexus Gene Lab Corp. Launches Redesigned Corporate Website
BioNexus Gene Lab Corp. has launched a redesigned corporate website to provide a more comprehensive overview of its operations, subsidiaries, and development initiatives.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
12 Industrials Stocks Moving In Wednesday's After-Market Session
Gainers iPower (NASDAQ:IPW) shares increased by 16.3% to $1.21 during Wednesday's after-market session. The market value of their outstanding shares is at $1.4 million. As per the news, the Q4 earnings report came
8-K filing — BioNexus Gene Lab Corp (BGLC)
Filed: 2026-10-07 AccNo: 0001477932-26-006075 Size: 247 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
BioNexus Gene Lab Announces $3.5M All-Stock Deal For Exclusive 10-Year Malaysian Healthcare License To Ruanyun Edai's CogniAI Platform
RYET to Enter Malaysian Healthcare Through Exclusive Cogni AI License to BioNexus Gene Lab
Ruanyun Edai Technology Inc. (NASDAQ: RYET) has signed a definitive agreement to grant BioNexus Gene Lab Corp. (NASDAQ: BGLC) an exclusive 10-20 year license for its Cogni AI document-intelligence platform in Malaysian healthcare. RYET will receive 560,000 BGLC shares and a 10% royalty on qualifying technology receipts. The deal aligns with Malaysia's RM1 billion healthcare digitalization initiative, though neither company has secured government contracts yet.
Ruanyun Edai Technology Inks Agreement To Grant License To BioNexus Gene Lab For Its Cogni AI Document-Intelligence Platform For Healthcare In Malaysia